Unity Biotechnology, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
UBX Nasdaq 2830 unitybiotechnology.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Unity Biotechnology, Inc.

Unity Stock Crashes Nearly 50% After Nasdaq Delisting Notice - Jun 30th, 2025 4:32 pm
Bluebird pleads for deal support; Unity, Mersana lay off staff - May 6th, 2025 4:19 am
UNITY Biotechnology Announces Complete 36-Week Results from the ASPIRE Phase 2b Study of UBX1325 in Diabetic Macular Edema and Provides Corporate Updates - May 5th, 2025 6:00 am
UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting - May 1st, 2025 6:00 am
UNITY Biotechnology Announces Publication in NEJM Evidence Highlighting the Potential of Senolytic Therapeutics to Provide Long-Term Improvements in Vision in DME - Apr 23rd, 2025 6:00 am
UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates - Apr 22nd, 2025 2:30 pm
UBX Stock Down 29% on Mixed Results From Phase II Eye Disease Study - Mar 25th, 2025 9:51 am
Unity reports topline outcomes from trial of diabetic macular oedema therapy - Mar 25th, 2025 6:07 am
UNITY Biotechnology Shares Drop 33% After Phase 2b Trial Data on UBX1325 in Diabetic Macular Edema - Mar 24th, 2025 9:36 am
UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema - Mar 24th, 2025 5:01 am
UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025 - Mar 23rd, 2025 2:00 pm
UNITY Biotechnology Appoints Industry Leader and Ophthalmology Expert Yehia Hashad, M.D., to the Board of Directors - Mar 10th, 2025 6:00 am
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates - Mar 7th, 2025 2:30 pm
UNITY Biotechnology Reports Granting of New Employment Inducement Award - Jan 7th, 2025 2:10 pm
UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer - Jan 6th, 2025 6:00 am
We're Keeping An Eye On Unity Biotechnology's (NASDAQ:UBX) Cash Burn Rate - Jan 5th, 2025 5:10 am
UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates - Nov 4th, 2024 2:30 pm
UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024 - Sep 24th, 2024 6:00 am
UNITY Biotechnology to Participate in Upcoming Investor Conferences - Aug 12th, 2024 6:00 am
UNITY Biotechnology (UBX) Upgraded to Buy: Here's What You Should Know - Aug 9th, 2024 10:00 am